Xencor to Participate at Upcoming Investor Conferences
Xencor (NASDAQ:XNCR), a clinical-stage biopharmaceutical company focused on engineered antibodies for cancer and serious diseases treatment, has announced its participation in two major investor conferences. The company will present at the Piper Sandler 36th Annual Healthcare Conference in New York City on December 3, 2024, at 2:00 p.m. ET, and at the 7th Annual Evercore HealthCONx Conference in Coral Gables, Florida on December 4, 2024, at 3:50 p.m. ET. Live webcasts will be available on Xencor's website under the Investors section, with replays accessible for at least 30 days after the presentations.
Xencor (NASDAQ:XNCR), un'azienda biofarmaceutica in fase clinica focalizzata su anticorpi ingegnerizzati per il trattamento del cancro e delle malattie gravi, ha annunciato la sua partecipazione a due importanti conferenze per investitori. L'azienda presenterà alla Piper Sandler 36th Annual Healthcare Conference a New York City il 3 dicembre 2024, alle 14:00 ET, e alla 7th Annual Evercore HealthCONx Conference a Coral Gables, Florida, il 4 dicembre 2024, alle 15:50 ET. Saranno disponibili webcast dal vivo sul sito web di Xencor nella sezione Investitori, con registrazioni accessibili per almeno 30 giorni dopo le presentazioni.
Xencor (NASDAQ:XNCR), una empresa biofarmacéutica en etapa clínica enfocada en anticuerpos diseñados para el tratamiento del cáncer y enfermedades graves, ha anunciado su participación en dos importantes conferencias para inversores. La empresa presentará en la Piper Sandler 36th Annual Healthcare Conference en la ciudad de Nueva York el 3 de diciembre de 2024, a las 2:00 p.m. ET, y en la 7th Annual Evercore HealthCONx Conference en Coral Gables, Florida, el 4 de diciembre de 2024, a las 3:50 p.m. ET. Las transmisiones en vivo estarán disponibles en el sitio web de Xencor en la sección de Inversionistas, con repeticiones accesibles durante al menos 30 días después de las presentaciones.
Xencor (NASDAQ:XNCR)는 암 및 중병 치료를 위한 조작 항체에 중점을 둔 임상 단계의 생물 제약 회사로, 두 개의 주요 투자자 회의에 참가할 것이라고 발표했습니다. 이 회사는 2024년 12월 3일 오후 2시 ET에 뉴욕시에서 열리는 Piper Sandler 36th Annual Healthcare Conference에서 발표할 예정이며, 2024년 12월 4일 오후 3시 50분 ET에 플로리다주 코랄 게이블스에서 열리는 7th Annual Evercore HealthCONx Conference에도 참가합니다. Xencor의 웹사이트 투자자 섹션에서 라이브 웹캐스트가 제공되며, 발표 후 최소 30일 동안 다시 볼 수 있습니다.
Xencor (NASDAQ:XNCR), une entreprise biopharmaceutique en phase clinique se concentrant sur les anticorps conçus pour le traitement du cancer et des maladies graves, a annoncé sa participation à deux grandes conférences pour investisseurs. L'entreprise présentera à la Piper Sandler 36th Annual Healthcare Conference à New York le 3 décembre 2024 à 14h00 ET, et à la 7th Annual Evercore HealthCONx Conference à Coral Gables, en Floride, le 4 décembre 2024 à 15h50 ET. Des webcasts en direct seront disponibles sur le site Web de Xencor dans la section investisseurs, avec des rediffusions accessibles pendant au moins 30 jours après les présentations.
Xencor (NASDAQ:XNCR), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf entwickelte Antikörper zur Behandlung von Krebs und schweren Krankheiten konzentriert, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen angekündigt. Das Unternehmen wird am 3. Dezember 2024 um 14:00 Uhr ET auf der Piper Sandler 36th Annual Healthcare Conference in New York City präsentieren und am 4. Dezember 2024 um 15:50 Uhr ET auf der 7th Annual Evercore HealthCONx Conference in Coral Gables, Florida. Live-Webcasts werden auf der Website von Xencor im Bereich Investoren verfügbar sein, mit Aufzeichnungen, die mindestens 30 Tage nach den Präsentationen zugänglich sind.
- None.
- None.
-
Piper Sandler 36th Annual Healthcare Conference
Date: Tuesday, December 3, 2024
Presentation Time: 2:00 p.m. ET / 11:00 a.m. PT
Location:New York City
-
7th Annual Evercore HealthCONx Conference
Date: Wednesday, December 4, 2024
Presentation Time: 3:50 p.m. ET / 12:50 p.m. PT
Location:Coral Gables, Florida
Live webcasts of the presentations will be available under “Events & Presentations” in the Investors section of the Company’s website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.
About Xencor
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and multiple XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein’s structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241126889211/en/
Charles Liles
cliles@xencor.com
(626) 737-8118
Source: Xencor, Inc.
FAQ
When is Xencor (XNCR) presenting at the Piper Sandler Healthcare Conference in 2024?
Where can investors watch Xencor's (XNCR) conference presentations in December 2024?
What conferences will Xencor (XNCR) attend in December 2024?
